High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice. Issue 9 (September 2016) - Tanguay, J.S.; Catlow, C.; Smith, C.; Barber, J.; Staffurth, J.; Kumar, S.; Palaniappan, N.; Button, M.; Mason, M.D.